Background: Lung adenocarcinoma is one of most threatening disease to human health.

The management of Stage I adenocarcinoma is supported by level II evidence.

Purpose: Current methods of assessing disease burden in gastric adenocarcinoma are imperfect.

Estrogen is considered to be associated with increasing risk of endometrial adenocarcinoma.

But most of these cases are a type of tumor called adenocarcinoma.